HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Rotraut Mössner Selected Research
Rotraut Mössner Research Topics
Disease
23
Psoriasis (Pustulosis Palmaris et Plantaris)
11/2023 - 01/2002
6
Psoriatic Arthritis
11/2023 - 06/2007
5
Melanoma (Melanoma, Malignant)
07/2016 - 09/2002
4
Pityriasis Rubra Pilaris
01/2024 - 03/2019
4
Neoplasms (Cancer)
07/2016 - 09/2002
3
Rheumatoid Arthritis
01/2022 - 09/2008
3
Inflammation (Inflammations)
06/2011 - 06/2004
2
Lichen Planus (Lichen Ruber Planus)
01/2022 - 12/2021
2
Pyoderma
01/2022 - 01/2022
2
Arthritis (Polyarthritis)
01/2022 - 05/2019
2
Eosinophilic Fasciitis
12/2021 - 08/2021
2
Acrodermatitis (Gianotti Crosti Syndrome)
10/2021 - 01/2019
2
Multiple Sclerosis
01/2021 - 04/2016
2
Hypersensitivity (Allergy)
01/2011 - 12/2003
1
Erythema
01/2023
1
Hidradenitis Suppurativa
11/2022
1
Localized Scleroderma (Morphea)
12/2021
1
Body Weight (Weight, Body)
12/2021
1
Sclerosis
12/2021
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
08/2021
1
Hypergammaglobulinemia (Hyperimmunoglobulinemia)
08/2021
1
Nicolau Syndrome
01/2021
1
Injection Site Reaction
01/2021
1
Skin Diseases (Skin Disease)
03/2019
1
Stevens-Johnson Syndrome (Lyell's Syndrome)
02/2018
1
Ankylosing Spondylitis
01/2018
1
Central Nervous System Diseases (CNS Diseases)
01/2018
1
Chronic Mucocutaneous Candidiasis
04/2016
1
Granuloma Annulare
03/2016
1
Necrosis
01/2011
1
Contact Dermatitis (Eczema, Contact)
01/2011
Drug/Important Bio-Agent (IBA)
6
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018 - 01/2002
5
Methotrexate (Mexate)
FDA Link
Generic
11/2023 - 11/2012
5
Infliximab (Remicade)
FDA Link
01/2018 - 03/2008
5
Proteins (Proteins, Gene)
FDA Link
07/2012 - 09/2002
4
Adalimumab (Humira)
FDA Link
01/2018 - 09/2008
4
Etanercept (Enbrel)
FDA Link
01/2018 - 09/2008
3
upadacitinib
IBA
01/2022 - 12/2021
3
risankizumab
IBA
08/2021 - 10/2020
3
Interleukin-17 (Interleukin 17)
IBA
01/2019 - 04/2016
3
Tumor Necrosis Factor Inhibitors
IBA
01/2009 - 03/2008
3
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
02/2007 - 09/2002
2
bimekizumab
IBA
01/2024 - 12/2023
2
apremilast
IBA
01/2023 - 05/2019
2
Interleukin-23 (Interleukin 23)
IBA
10/2021 - 02/2009
2
Interleukins
IBA
07/2018 - 01/2002
2
Antibodies
IBA
07/2016 - 09/2008
2
Glutathione Transferase (Glutathione S-Transferase)
IBA
01/2011 - 01/2007
2
Interleukin-16 (Interleukin 16)
IBA
01/2011 - 12/2003
2
PPAR gamma
IBA
02/2007 - 09/2002
2
PPAR alpha
IBA
06/2004 - 09/2002
2
Ligands
IBA
06/2004 - 09/2002
2
Cytokines
IBA
12/2003 - 01/2002
1
Immunoglobulin A (IgA)
IBA
11/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
11/2022
1
tofacitinib
IBA
01/2022
1
Intravenous Immunoglobulins (IVIG)
FDA Link
12/2021
1
Immunosuppressive Agents (Immunosuppressants)
IBA
12/2021
1
Glucocorticoids
IBA
12/2021
1
Prednisolone (Predate)
FDA Link
Generic
08/2021
1
Rituximab (Mabthera)
FDA Link
08/2021
1
Glatiramer Acetate (Copaxone)
FDA Link
01/2021
1
guselkumab
IBA
11/2020
1
tildrakizumab
IBA
11/2020
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
05/2019
1
brodalumab
IBA
05/2019
1
Interleukin-17 Receptors
IBA
05/2019
1
Isotretinoin (Accutane)
FDA Link
Generic
03/2019
1
Lipocalin-2
IBA
04/2018
1
Afatinib
IBA
02/2018
1
Ustekinumab (CNTO 1275)
FDA Link
01/2017
1
Monoclonal Antibodies
IBA
07/2016
1
Immune Checkpoint Inhibitors
IBA
07/2016
1
ruxolitinib
IBA
04/2016
1
Interferon-beta
IBA
04/2016
1
Vemurafenib
IBA
03/2016
1
Leflunomide (Arava)
FDA Link
Generic
01/2015
1
Acitretin
FDA Link
01/2015
1
Fumarates
IBA
01/2015
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
01/2015
1
25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)
IBA
07/2012
1
1,25-dihydroxyvitamin D
IBA
07/2012
1
Genetic Markers (Genetic Marker)
IBA
07/2012
1
Mixed Function Oxygenases (Monooxygenases)
IBA
07/2012
1
Vitamin D
FDA Link
Generic
07/2012
1
Vitamin D-Binding Protein
IBA
07/2012
1
Calcitriol Receptors (Calcitriol Receptor)
IBA
07/2012
1
Vitamin D3 24-Hydroxylase
IBA
07/2012
1
Paraffin
IBA
06/2011
1
Anti-Idiotypic Antibodies
IBA
06/2011
1
Formaldehyde (Formol)
FDA Link
06/2011
1
Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
IBA
01/2011
1
N-acetyltalosaminuronic acid (NAT)
IBA
01/2011
1
Filaggrin Proteins
IBA
01/2011
1
Irritants (Vesicants)
IBA
01/2011
1
Superoxide Dismutase
IBA
01/2011
Therapy/Procedure
10
Therapeutics
11/2023 - 03/2008
1
Aftercare (After-Treatment)
12/2021
1
Intra-Articular Injections
01/2021
1
Subcutaneous Injections
01/2021